StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
RENX

Renalytix plc

RENXF OTC Services-Medical Laboratories EDGAR ↗

Key statistics

from XBRL data in SEC filings
Market cap
Revenue (TTM)
$2.35M
Net income (TTM)
-$28.0M
EPS (TTM)
$-0.24
P/E ratio
Dividend yield
Free cash flow
Cash
$909K
Total assets
$4.79M
Gross margin
12.7%
52-week range

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jan 16, 2025 8-K Shareholder vote results; Regulation FD disclosure Dec 20, 2024 8-K/A Entered a material agreement; Took on a direct financial obligation Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Nov 6, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Took on a direct financial obligation; Delisting notice or listing-rule failure; Unregistered sale of equity; Other events Oct 1, 2024 10-K Fiscal year ended 2024-06-30 Sep 30, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Aug 27, 2024 8-K Unregistered sale of equity; Regulation FD disclosure Jul 15, 2024 8-K/A Changed accountants Jun 25, 2024 8-K Delisting notice or listing-rule failure Jun 24, 2024 8-K Changed accountants Jun 24, 2024 8-K Regulation FD disclosure Jun 17, 2024 8-K Director or officer change Jun 12, 2024 8-K Director or officer change; Regulation FD disclosure May 28, 2024 8-K Entered a material agreement May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 26, 2024 8-K Entered a material agreement; Director or officer change; Shareholder vote results Apr 23, 2024 8-K Unregistered sale of equity; Regulation FD disclosure Apr 10, 2024 8-K Entered a material agreement Apr 9, 2024 8-K Regulation FD disclosure Apr 8, 2024 8-K Entered a material agreement Mar 29, 2024 8-K Regulation FD disclosure Mar 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 13, 2024 8-K Regulation FD disclosure Mar 4, 2024 8-K Regulation FD disclosure Feb 29, 2024 8-K Results of operations (earnings release) Feb 15, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 8-K Regulation FD disclosure Feb 9, 2024 8-K Regulation FD disclosure Jan 17, 2024 8-K Regulation FD disclosure Jan 10, 2024 8-K Delisting notice or listing-rule failure Dec 29, 2023 8-K Unregistered sale of equity; Regulation FD disclosure Dec 18, 2023 8-K Shareholder vote results Dec 18, 2023 8-K Director or officer change Dec 8, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Nov 14, 2023 8-K Regulation FD disclosure Oct 31, 2023